Table 2.

Clinical features of likely pediatric inflammatory bowel disease (PIBD) cases presented with suspected severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) symptoms.

Patient	Disease	Paris classification	Treatment	Disease activity	Symptoms	COVID-19 contact/nasopharyngeal swab
1	UC	E4	5-ASA	Remission	Cough	No/not done
2	CD	L3	ADA	Remission	Cough	No/not done
3	CD	L3	AZA	Remission	Fever	No/not done
4	CD	L3 + L4a	AZA	Remission	Myalgia, fatigue	Yes/not done
5	CD	L3	AZA	Remission	Fever	No/not done
6	CD	L2	AZA	Remission	Fever	No/not done
7	CD	L2	AZA	Remission	Fever	No/not done
8	UC	E4	5-ASA	Remission	Fever	No/not done
9	UC	E4	AZA	Mild	Fever	Yes/negative
10	UC	E2	5-ASA	Remission	Diarrhea	No/not done
11	UC	E2	AZA	Remission	Fever	No/not done
12	UC	E2	5-ASA	Remission	Fever	No/not done
13	CD	L3	IFX	Remission	Fever, fatigue	Yes/positive
14	UC	E2	5-ASA	Mild	Cough	No/not done
15	CD	L1	AZA	Remission	Fever, cough	No/not done
16	IBD-U	E1	Off-therapy	Remission	Fever	No/not done
17	UC	E4	Off-therapy	Remission	Fever, cough	No/not done
18	CD	L3	AZA	Remission	Fever, vomiting, diarrhea	No/not done
19	UC	E4	5-ASA	Remission	Fever	No/not done
20	UC	E4	5-ASA	Remission	Fever	No/not done
21	CD	L3	IFX	Remission	Fever, rhinitis	No/not done
22	CD	L3	AZA	Remission	Fever, cough	No/not done
23	CD	L1	CDED	Remission	Fever, fatigue	No/not done
24	UC	E4	IFX	Remission	Fever, cough, rhinitis	No/not done

ADA, adalimumab; 5-ASA, salicylates; AZA, azathioprine, CD, Crohn's disease; CED, Crohn disease exclusion diet; IFX, infliximab; UC, ulcerative colitis.